Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects
Faglia E, Mantero M, Caminiti M, Caravaggi C, De Giglio R, Pritelli C, Clerici G, Fratino P, De Cata P, Paola LD, Mariani G, Poli M, Settembrini PG, Sciangula L, Morabito A, Graziani L (Internal Medicine Unit, Diabetology Centre, Policlinico Multimedica, Sesto San Giovanni, Milano; Centre for the St...
Saved in:
Published in | Journal of internal medicine Vol. 252; no. 3; pp. 225 - 232 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford UK
Blackwell Science Ltd
01.09.2002
Blackwell Science |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Faglia E, Mantero M, Caminiti M, Caravaggi C, De Giglio R, Pritelli C, Clerici G, Fratino P, De Cata P, Paola LD, Mariani G, Poli M, Settembrini PG, Sciangula L, Morabito A, Graziani L (Internal Medicine Unit, Diabetology Centre, Policlinico Multimedica, Sesto San Giovanni, Milano; Centre for the Study and Treatment of Diabetic Foot Pathology, Abbiategrasso Hospital, Milano; Internal Medicine Unit, IRCCS Salvatore Maugeri Foundation, Pavia; Endocrinology and Metabolism Unit, Diabetic Foot Centre, Villa Berica Hospital, Vicenza Italy; Diabetology Centre and Vascular Surgery Division, S. Carlo Borromeo Hospital, Milano; Diabetology Centre, `Felice Villa' Hospital, Mariano Comense Como; Department of Medicine, Surgery and Dentistry, S. Paolo Hospital, University of Milan, Cardiovascular Catheterization Laboratory, `Città di Brescia' Hospital, Brescia, Italy). Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. J Intern Med 2002; 252: 225–232.
Objectives. To evaluate the feasibility, technical effectiveness and limb salvage potential of percutaneous transluminal angioplasty (PTA), particularly infrapopliteal, in diabetic subjects with ischaemic foot ulcer.
Design. Intervention study with PTA in consecutive series.
Setting. Six Diabetology Foot Centres and one Cardiovascular Catheterization Laboratory in Italy.
Subjects. Two hundred and twenty‐one consecutive diabetic subjects hospitalized for ischaemic foot ulcer.
Interventions. Peripheral arterial occlusive disease (PAOD) was investigated by means of foot pulses assessment, ankle‐brachial‐index (ABI), transcutaneous oxygen tension (TcPO2) and duplex scanning. If non‐invasive parameters suggested PAOD, angiography was performed and a PTA was carried out during the same session.
Main outcome measures. PTA feasibility, improvement of ABI and TcPO2, limb salvage rate, clinical recurrence.
Results. On angiography, two patients had stenoses which were <50% of the vessel diameter. PTA was performed in 191 (85.3%) of the 219 subjects with stenoses >50%, even when longer than 10 cm and/or multiple/calcified. In 11 patients (5.8%) PTA was performed in the proximal axis exclusively, in 81 (42.4%) patients in the infrapopliteal axis exclusively and in 99 (51.8%) in both the femoropopliteal and infrapopliteal axis. Both ABI and TcPO2 improved significantly after PTA (P < 0.0001). Clinical recurrence occurred in 14 subjects: 10 of whom underwent a second successful PTA. Of the 191 patients who underwent PTA, 10 (5.2%) underwent an above‐the‐ankle amputation.
Conclusions. PTA, including infrapopliteal, is feasible in most diabetic subjects with ischaemic foot ulcer and is effective for foot revascularization. Clinical recurrence was infrequent and the procedure could successfully be repeated in most cases. In subjects treated successfully with PTA the above‐the‐ankle amputation rate was low. PTA should be considered as the revascularization treatment of first choice in all diabetic subjects with foot ulcer and PAOD. |
---|---|
AbstractList | To evaluate the feasibility, technical effectiveness and limb salvage potential of percutaneous transluminal angioplasty (PTA), particularly infrapopliteal, in diabetic subjects with ischaemic foot ulcer.
Intervention study with PTA in consecutive series.
Six Diabetology Foot Centres and one Cardiovascular Catheterization Laboratory in Italy.
Two hundred and twenty-one consecutive diabetic subjects hospitalized for ischaemic foot ulcer.
Peripheral arterial occlusive disease (PAOD) was investigated by means of foot pulses assessment, ankle-brachial-index (ABI), transcutaneous oxygen tension (TcPO2) and duplex scanning. If non-invasive parameters suggested PAOD, angiography was performed and a PTA was carried out during the same session.
PTA feasibility, improvement of ABI and TcPO2, limb salvage rate, clinical recurrence.
On angiography, two patients had stenoses which were <50% of the vessel diameter. PTA was performed in 191 (85.3%) of the 219 subjects with stenoses >50%, even when longer than 10 cm and/or multiple/calcified. In 11 patients (5.8%) PTA was performed in the proximal axis exclusively, in 81 (42.4%) patients in the infrapopliteal axis exclusively and in 99 (51.8%) in both the femoropopliteal and infrapopliteal axis. Both ABI and TcPO2 improved significantly after PTA (P < 0.0001). Clinical recurrence occurred in 14 subjects: 10 of whom underwent a second successful PTA. Of the 191 patients who underwent PTA, 10 (5.2%) underwent an above-the-ankle amputation.
PTA, including infrapopliteal, is feasible in most diabetic subjects with ischaemic foot ulcer and is effective for foot revascularization. Clinical recurrence was infrequent and the procedure could successfully be repeated in most cases. In subjects treated successfully with PTA the above-the-ankle amputation rate was low. PTA should be considered as the revascularization treatment of first choice in all diabetic subjects with foot ulcer and PAOD. Abstract Faglia E, Mantero M, Caminiti M, Caravaggi C, De Giglio R, Pritelli C, Clerici G, Fratino P, De Cata P, Paola LD, Mariani G, Poli M, Settembrini PG, Sciangula L, Morabito A, Graziani L (Internal Medicine Unit, Diabetology Centre, Policlinico Multimedica, Sesto San Giovanni, Milano; Centre for the Study and Treatment of Diabetic Foot Pathology, Abbiategrasso Hospital, Milano; Internal Medicine Unit, IRCCS Salvatore Maugeri Foundation, Pavia; Endocrinology and Metabolism Unit, Diabetic Foot Centre, Villa Berica Hospital, Vicenza Italy; Diabetology Centre and Vascular Surgery Division, S. Carlo Borromeo Hospital, Milano; Diabetology Centre, `Felice Villa' Hospital, Mariano Comense Como; Department of Medicine, Surgery and Dentistry, S. Paolo Hospital, University of Milan, Cardiovascular Catheterization Laboratory, `Città di Brescia' Hospital, Brescia, Italy). Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. J Intern Med 2002; 252: 225–232. Objectives. To evaluate the feasibility, technical effectiveness and limb salvage potential of percutaneous transluminal angioplasty (PTA), particularly infrapopliteal, in diabetic subjects with ischaemic foot ulcer. Design. Intervention study with PTA in consecutive series. Setting. Six Diabetology Foot Centres and one Cardiovascular Catheterization Laboratory in Italy. Subjects. Two hundred and twenty‐one consecutive diabetic subjects hospitalized for ischaemic foot ulcer. Interventions. Peripheral arterial occlusive disease (PAOD) was investigated by means of foot pulses assessment, ankle‐brachial‐index (ABI), transcutaneous oxygen tension (TcPO 2 ) and duplex scanning. If non‐invasive parameters suggested PAOD, angiography was performed and a PTA was carried out during the same session. Main outcome measures. PTA feasibility, improvement of ABI and TcPO 2 , limb salvage rate, clinical recurrence. Results. On angiography, two patients had stenoses which were <50% of the vessel diameter. PTA was performed in 191 (85.3%) of the 219 subjects with stenoses >50%, even when longer than 10 cm and/or multiple/calcified. In 11 patients (5.8%) PTA was performed in the proximal axis exclusively, in 81 (42.4%) patients in the infrapopliteal axis exclusively and in 99 (51.8%) in both the femoropopliteal and infrapopliteal axis. Both ABI and TcPO 2 improved significantly after PTA ( P < 0.0001). Clinical recurrence occurred in 14 subjects: 10 of whom underwent a second successful PTA. Of the 191 patients who underwent PTA, 10 (5.2%) underwent an above‐the‐ankle amputation. Conclusions. PTA, including infrapopliteal, is feasible in most diabetic subjects with ischaemic foot ulcer and is effective for foot revascularization. Clinical recurrence was infrequent and the procedure could successfully be repeated in most cases. In subjects treated successfully with PTA the above‐the‐ankle amputation rate was low. PTA should be considered as the revascularization treatment of first choice in all diabetic subjects with foot ulcer and PAOD. To evaluate the feasibility, technical effectiveness and limb salvage potential of percutaneous transluminal angioplasty (PTA), particularly infrapopliteal, in diabetic subjects with ischaemic foot ulcer.OBJECTIVETo evaluate the feasibility, technical effectiveness and limb salvage potential of percutaneous transluminal angioplasty (PTA), particularly infrapopliteal, in diabetic subjects with ischaemic foot ulcer.Intervention study with PTA in consecutive series.DESIGNIntervention study with PTA in consecutive series.Six Diabetology Foot Centres and one Cardiovascular Catheterization Laboratory in Italy.SETTINGSix Diabetology Foot Centres and one Cardiovascular Catheterization Laboratory in Italy.Two hundred and twenty-one consecutive diabetic subjects hospitalized for ischaemic foot ulcer.SUBJECTSTwo hundred and twenty-one consecutive diabetic subjects hospitalized for ischaemic foot ulcer.Peripheral arterial occlusive disease (PAOD) was investigated by means of foot pulses assessment, ankle-brachial-index (ABI), transcutaneous oxygen tension (TcPO2) and duplex scanning. If non-invasive parameters suggested PAOD, angiography was performed and a PTA was carried out during the same session.INTERVENTIONPeripheral arterial occlusive disease (PAOD) was investigated by means of foot pulses assessment, ankle-brachial-index (ABI), transcutaneous oxygen tension (TcPO2) and duplex scanning. If non-invasive parameters suggested PAOD, angiography was performed and a PTA was carried out during the same session.PTA feasibility, improvement of ABI and TcPO2, limb salvage rate, clinical recurrence.MAIN OUTCOME MEASURESPTA feasibility, improvement of ABI and TcPO2, limb salvage rate, clinical recurrence.On angiography, two patients had stenoses which were <50% of the vessel diameter. PTA was performed in 191 (85.3%) of the 219 subjects with stenoses >50%, even when longer than 10 cm and/or multiple/calcified. In 11 patients (5.8%) PTA was performed in the proximal axis exclusively, in 81 (42.4%) patients in the infrapopliteal axis exclusively and in 99 (51.8%) in both the femoropopliteal and infrapopliteal axis. Both ABI and TcPO2 improved significantly after PTA (P < 0.0001). Clinical recurrence occurred in 14 subjects: 10 of whom underwent a second successful PTA. Of the 191 patients who underwent PTA, 10 (5.2%) underwent an above-the-ankle amputation.RESULTSOn angiography, two patients had stenoses which were <50% of the vessel diameter. PTA was performed in 191 (85.3%) of the 219 subjects with stenoses >50%, even when longer than 10 cm and/or multiple/calcified. In 11 patients (5.8%) PTA was performed in the proximal axis exclusively, in 81 (42.4%) patients in the infrapopliteal axis exclusively and in 99 (51.8%) in both the femoropopliteal and infrapopliteal axis. Both ABI and TcPO2 improved significantly after PTA (P < 0.0001). Clinical recurrence occurred in 14 subjects: 10 of whom underwent a second successful PTA. Of the 191 patients who underwent PTA, 10 (5.2%) underwent an above-the-ankle amputation.PTA, including infrapopliteal, is feasible in most diabetic subjects with ischaemic foot ulcer and is effective for foot revascularization. Clinical recurrence was infrequent and the procedure could successfully be repeated in most cases. In subjects treated successfully with PTA the above-the-ankle amputation rate was low. PTA should be considered as the revascularization treatment of first choice in all diabetic subjects with foot ulcer and PAOD.CONCLUSIONSPTA, including infrapopliteal, is feasible in most diabetic subjects with ischaemic foot ulcer and is effective for foot revascularization. Clinical recurrence was infrequent and the procedure could successfully be repeated in most cases. In subjects treated successfully with PTA the above-the-ankle amputation rate was low. PTA should be considered as the revascularization treatment of first choice in all diabetic subjects with foot ulcer and PAOD. Faglia E, Mantero M, Caminiti M, Caravaggi C, De Giglio R, Pritelli C, Clerici G, Fratino P, De Cata P, Paola LD, Mariani G, Poli M, Settembrini PG, Sciangula L, Morabito A, Graziani L (Internal Medicine Unit, Diabetology Centre, Policlinico Multimedica, Sesto San Giovanni, Milano; Centre for the Study and Treatment of Diabetic Foot Pathology, Abbiategrasso Hospital, Milano; Internal Medicine Unit, IRCCS Salvatore Maugeri Foundation, Pavia; Endocrinology and Metabolism Unit, Diabetic Foot Centre, Villa Berica Hospital, Vicenza Italy; Diabetology Centre and Vascular Surgery Division, S. Carlo Borromeo Hospital, Milano; Diabetology Centre, `Felice Villa' Hospital, Mariano Comense Como; Department of Medicine, Surgery and Dentistry, S. Paolo Hospital, University of Milan, Cardiovascular Catheterization Laboratory, `Città di Brescia' Hospital, Brescia, Italy). Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. J Intern Med 2002; 252: 225–232. Objectives. To evaluate the feasibility, technical effectiveness and limb salvage potential of percutaneous transluminal angioplasty (PTA), particularly infrapopliteal, in diabetic subjects with ischaemic foot ulcer. Design. Intervention study with PTA in consecutive series. Setting. Six Diabetology Foot Centres and one Cardiovascular Catheterization Laboratory in Italy. Subjects. Two hundred and twenty‐one consecutive diabetic subjects hospitalized for ischaemic foot ulcer. Interventions. Peripheral arterial occlusive disease (PAOD) was investigated by means of foot pulses assessment, ankle‐brachial‐index (ABI), transcutaneous oxygen tension (TcPO2) and duplex scanning. If non‐invasive parameters suggested PAOD, angiography was performed and a PTA was carried out during the same session. Main outcome measures. PTA feasibility, improvement of ABI and TcPO2, limb salvage rate, clinical recurrence. Results. On angiography, two patients had stenoses which were <50% of the vessel diameter. PTA was performed in 191 (85.3%) of the 219 subjects with stenoses >50%, even when longer than 10 cm and/or multiple/calcified. In 11 patients (5.8%) PTA was performed in the proximal axis exclusively, in 81 (42.4%) patients in the infrapopliteal axis exclusively and in 99 (51.8%) in both the femoropopliteal and infrapopliteal axis. Both ABI and TcPO2 improved significantly after PTA (P < 0.0001). Clinical recurrence occurred in 14 subjects: 10 of whom underwent a second successful PTA. Of the 191 patients who underwent PTA, 10 (5.2%) underwent an above‐the‐ankle amputation. Conclusions. PTA, including infrapopliteal, is feasible in most diabetic subjects with ischaemic foot ulcer and is effective for foot revascularization. Clinical recurrence was infrequent and the procedure could successfully be repeated in most cases. In subjects treated successfully with PTA the above‐the‐ankle amputation rate was low. PTA should be considered as the revascularization treatment of first choice in all diabetic subjects with foot ulcer and PAOD. |
Author | Faglia, E. Sciangula, L. Mantero, M. Clerici, G. Caminiti, M. Poli, M. Morabito, A. Pritelli, C. Mariani, G. CaravaggI, C. De Cata, P. Fratino, P. Graziani, L. De Giglio, R. Paola, L. Dalla Settembrini, P. G. |
Author_xml | – sequence: 1 givenname: E. surname: Faglia fullname: Faglia, E. – sequence: 2 givenname: M. surname: Mantero fullname: Mantero, M. – sequence: 3 givenname: M. surname: Caminiti fullname: Caminiti, M. – sequence: 4 givenname: C. surname: CaravaggI fullname: CaravaggI, C. – sequence: 5 givenname: R. surname: De Giglio fullname: De Giglio, R. – sequence: 6 givenname: C. surname: Pritelli fullname: Pritelli, C. – sequence: 7 givenname: G. surname: Clerici fullname: Clerici, G. – sequence: 8 givenname: P. surname: Fratino fullname: Fratino, P. – sequence: 9 givenname: P. surname: De Cata fullname: De Cata, P. – sequence: 10 givenname: L. Dalla surname: Paola fullname: Paola, L. Dalla – sequence: 11 givenname: G. surname: Mariani fullname: Mariani, G. – sequence: 12 givenname: M. surname: Poli fullname: Poli, M. – sequence: 13 givenname: P. G. surname: Settembrini fullname: Settembrini, P. G. – sequence: 14 givenname: L. surname: Sciangula fullname: Sciangula, L. – sequence: 15 givenname: A. surname: Morabito fullname: Morabito, A. – sequence: 16 givenname: L. surname: Graziani fullname: Graziani, L. |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13888063$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/12270002$$D View this record in MEDLINE/PubMed |
BookMark | eNqVkk1v1DAQhi1URLeFv4B8gVMTbOebAxKqChQV9QJnazKZZb1yPrAd2PxC_hYOXVqJE5w89jzvO_Z4ztjJMA7EGJcilSIvX-1TmZVFoqqmTJUQKhVSyCI9PGKb-8QJ24imyJOyVuKUnXm_F0JmohRP2KlUqhJRt2E_rw6BBm--E5898XHLJ3Jm2pEDy2H4asbJgg_LBZ_ABYOzBWcXboatgynmTCCwF3HPw454cAShpyGsRsbjDqg3yDsDLUUx345j4LNFcv41R2sGg7GMIz_b4FcN8D6GBqOFi7wPc7es50pJjuPgCeew3vXe0c_tnjD4p-zxFqynZ8f1nH15d_X58kNyc_v--vLtTYKFzIukBtHV2HRZVzVYdg2ClG3b1m1ZiVbmVYZFXhYKuqZUjeryArKuQIHUNrlQCrNz9vLOd3Ljt5l80H18J1kLA42z15WSqlCyiuDzIzi3PXV6cqYHt-g_rY_AiyMAPnYh9nNA4x-4rK5rUWaRq-84dKP3jrYPiNDrNOi9Xj9dr5-u12nQv6dBH6L0zV9SNAGCGWN3wdj_MPhhLC3_XFh_vL3-tIbZL4fZ0t8 |
CitedBy_id | crossref_primary_10_1007_s11936_014_0332_3 crossref_primary_10_3390_medicina59020200 crossref_primary_10_2337_dc10_0939 crossref_primary_10_1111_iwj_12174 crossref_primary_10_1002_dmrr_2258 crossref_primary_10_1002_dmrr_2259 crossref_primary_10_1016_j_jvs_2006_09_038 crossref_primary_10_1253_circj_CJ_11_0552 crossref_primary_10_5999_aps_2014_41_6_788 crossref_primary_10_1016_j_rcl_2008_08_004 crossref_primary_10_1016_j_angio_2016_08_002 crossref_primary_10_1007_s10103_021_03393_z crossref_primary_10_1177_145749690709600103 crossref_primary_10_1016_j_ejrad_2010_04_014 crossref_primary_10_1016_S1166_4568_09_45142_8 crossref_primary_10_4244_EIJV3I4A84 crossref_primary_10_1002_ccd_20930 crossref_primary_10_1007_s40520_013_0033_x crossref_primary_10_1177_15266028221106312 crossref_primary_10_1016_j_cpcardiol_2009_05_001 crossref_primary_10_1002_ccd_22781 crossref_primary_10_1016_j_ejvs_2005_02_035 crossref_primary_10_3238_arztebl_2012_0095 crossref_primary_10_1016_j_avsg_2014_02_002 crossref_primary_10_1177_1534734605280597 crossref_primary_10_1016_j_mcna_2013_04_002 crossref_primary_10_1016_j_ejvs_2009_10_018 crossref_primary_10_1016_S1262_3636_07_70206_9 crossref_primary_10_1016_j_jcte_2014_10_002 crossref_primary_10_1002_dmrr_2249 crossref_primary_10_2337_diacare_26_6_1874 crossref_primary_10_1186_s43055_019_0106_8 crossref_primary_10_1016_j_jvs_2010_06_003 crossref_primary_10_1007_s00547_006_2073_y crossref_primary_10_1111_j_1464_5491_2007_02167_x crossref_primary_10_1016_j_jvs_2005_03_018 crossref_primary_10_1016_j_numecd_2019_11_009 crossref_primary_10_1177_1534734614549416 crossref_primary_10_1016_j_jvir_2019_10_025 crossref_primary_10_1111_1753_0407_13094 crossref_primary_10_1177_1526602815573229 crossref_primary_10_1007_s00772_014_1339_5 crossref_primary_10_1016_j_jvs_2015_10_004 crossref_primary_10_1007_s00270_005_0276_9 crossref_primary_10_1016_j_avsg_2011_08_014 crossref_primary_10_1016_j_acvfr_2010_03_005 crossref_primary_10_1016_j_jacc_2006_02_024 crossref_primary_10_1016_j_jvs_2008_02_027 crossref_primary_10_1016_j_ejrnm_2016_03_017 crossref_primary_10_1007_s00117_009_1911_2 crossref_primary_10_1016_j_acvsp_2009_11_009 crossref_primary_10_1016_j_jvs_2011_02_006 crossref_primary_10_1016_S1078_5884_11_60012_9 crossref_primary_10_1177_1938640010382037 crossref_primary_10_1097_01_prs_0000225459_93750_29 crossref_primary_10_1016_j_diabet_2015_05_004 crossref_primary_10_1089_wound_2017_0778 crossref_primary_10_7759_cureus_73722 crossref_primary_10_1007_s00270_010_9968_x crossref_primary_10_1007_s11547_013_0930_2 crossref_primary_10_1016_j_diabres_2011_10_033 crossref_primary_10_1186_1745_6215_12_69 crossref_primary_10_1055_a_2491_3381 crossref_primary_10_1177_1534734612463701 crossref_primary_10_1016_j_angio_2012_03_003 crossref_primary_10_3348_kjr_2013_14_3_430 crossref_primary_10_1007_s13239_014_0192_8 crossref_primary_10_1590_S1677_54492008000200016 crossref_primary_10_1002_dmrr_2705 crossref_primary_10_1583_10_3260_1 crossref_primary_10_1007_s00270_010_9890_2 crossref_primary_10_1111_j_1464_5491_2010_03192_x crossref_primary_10_1080_00015458_2008_11680246 crossref_primary_10_1016_j_diabres_2008_01_023 crossref_primary_10_1016_j_jmv_2014_12_007 crossref_primary_10_21518_2307_1109_2019_1_25_35 crossref_primary_10_1016_j_avsg_2013_02_008 crossref_primary_10_1016_j_jvs_2004_11_041 crossref_primary_10_3400_avd_pad_16_01000 crossref_primary_10_1111_micc_12527 crossref_primary_10_1179_acb_2007_037 crossref_primary_10_1002_dmrr_2266 crossref_primary_10_1155_2014_672897 crossref_primary_10_1053_j_tvir_2004_01_004 crossref_primary_10_1016_S0003_3170_09_15003_4 crossref_primary_10_1007_s00117_006_1423_2 crossref_primary_10_3348_kjr_2016_17_6_874 crossref_primary_10_1007_s00117_006_1426_z crossref_primary_10_1177_1534734616667865 crossref_primary_10_1007_s00392_012_0471_z crossref_primary_10_1016_j_avsg_2009_05_007 crossref_primary_10_1016_j_fcl_2006_06_013 crossref_primary_10_1583_09_2819_1 crossref_primary_10_5551_jat_9951 crossref_primary_10_1016_S0003_3170_04_74843_9 crossref_primary_10_1016_j_avsg_2007_07_018 crossref_primary_10_1016_j_carrev_2016_02_001 crossref_primary_10_1007_s00270_010_9941_8 crossref_primary_10_1016_j_ejvs_2006_11_022 crossref_primary_10_1016_j_ejvs_2013_04_013 crossref_primary_10_3402_dfa_v1i0_5438 crossref_primary_10_1146_annurev_med_56_082103_104649 crossref_primary_10_1177_152660280301000330 crossref_primary_10_3348_jksr_2016_74_3_169 crossref_primary_10_1007_s11892_011_0195_x crossref_primary_10_1583_10_3242_1 crossref_primary_10_4103_ejs_ejs_32_23 crossref_primary_10_1177_1708538118805623 crossref_primary_10_1177_1534734618813232 crossref_primary_10_1016_j_numecd_2013_12_007 crossref_primary_10_1016_S1762_827X_18_41662_8 crossref_primary_10_1583_08_2423_1 crossref_primary_10_1016_j_carrev_2018_08_021 crossref_primary_10_1177_1526602817698897 crossref_primary_10_1016_j_jrm_2010_07_001 crossref_primary_10_1111_j_1540_8183_2011_00676_x crossref_primary_10_1016_S1762_827X_12_61069_4 crossref_primary_10_1016_j_cpm_2007_03_001 crossref_primary_10_4103_ksj_ksj_18_22 crossref_primary_10_1007_s00270_007_9214_3 crossref_primary_10_1016_j_jvs_2010_10_088 crossref_primary_10_1053_j_semvascsurg_2012_04_006 crossref_primary_10_1016_j_acvfr_2010_09_035 crossref_primary_10_1016_j_jvs_2014_05_009 crossref_primary_10_1111_j_1540_8183_2008_00350_x crossref_primary_10_1111_j_1067_1927_2004_012104_x crossref_primary_10_1016_j_ejvs_2014_07_001 crossref_primary_10_1016_j_acvfr_2008_02_026 crossref_primary_10_1007_s00772_010_0827_5 crossref_primary_10_1097_SAP_0000000000001500 crossref_primary_10_1177_1534734611417352 crossref_primary_10_1016_j_ejvs_2006_03_006 crossref_primary_10_1016_j_jvir_2007_03_012 crossref_primary_10_1583_1545_1550_2003_010_0614_PRTAIL_2_0_CO_2 crossref_primary_10_1016_S1155_1941_11_51218_1 crossref_primary_10_1371_journal_pone_0086405 crossref_primary_10_1016_j_avsg_2009_07_034 crossref_primary_10_1002_dmrr_834 crossref_primary_10_1002_dmrr_955 crossref_primary_10_1007_s00772_007_0517_0 crossref_primary_10_1583_08_2460_1 crossref_primary_10_1016_j_jdiacomp_2009_02_003 crossref_primary_10_1182_asheducation_2003_1_540 crossref_primary_10_1016_j_avsg_2017_06_135 crossref_primary_10_1016_S1879_8535_06_74666_9 crossref_primary_10_1016_S0891_8422_03_00088_0 crossref_primary_10_1016_j_bjps_2010_11_024 crossref_primary_10_1097_00060793_200308000_00005 crossref_primary_10_1177_1938640007312316 crossref_primary_10_1097_00001573_200311000_00003 crossref_primary_10_1016_j_ejvs_2018_05_009 crossref_primary_10_15420_ver_2022_08 crossref_primary_10_3724_SP_J_1263_2011_00078 crossref_primary_10_1002_dmrr_2866 crossref_primary_10_1016_j_addr_2006_01_024 crossref_primary_10_1016_j_jvs_2009_05_026 crossref_primary_10_1016_j_angio_2012_09_001 crossref_primary_10_1111_wrr_12029 crossref_primary_10_1016_j_jvs_2012_10_104 crossref_primary_10_4103_ijves_ijves_69_20 crossref_primary_10_1177_0003319712465172 crossref_primary_10_1177_1358863X10384534 |
Cites_doi | 10.2337/diacare.18.10.1383 10.1161/01.CIR.89.1.511 10.1024/0301-1526.28.4.271 10.2337/diacare.24.1.78 10.1016/S1056-8727(97)98004-1 10.1148/radiology.200.1.8657939 10.1053/ejvs.1998.0806 10.1056/NEJM199409293311307 10.1016/S0002-9610(99)00149-X 10.1055/s-2007-1015156 10.1002/bjs.1800820925 10.1002/dme.1996.13.s1.6 10.1177/107110079601700110 10.1001/archsurg.1992.01420050145019 10.1016/S1051-0443(07)61332-3 10.1016/S0140-6736(01)06351-6 10.2214/ajr.172.5.10227512 |
ContentType | Journal Article |
Copyright | 2002 INIST-CNRS |
Copyright_xml | – notice: 2002 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1046/j.1365-2796.2002.01015.x |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1365-2796 |
EndPage | 232 |
ExternalDocumentID | 12270002 13888063 10_1046_j_1365_2796_2002_01015_x JOIM1015 |
Genre | article Clinical Trial Multicenter Study Journal Article |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 24P 29K 2WC 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AI. AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F D-I DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO E3Z EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FIJ FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IPNFZ IX1 J0M KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N4W N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SJN SUPJJ TEORI TR2 UB1 V8K V9Y VH1 VVN W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 YFH YOC YUY ZCG ZGI ZXP ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY IQODW CGR CUY CVF ECM EIF NPM PKN 7X8 |
ID | FETCH-LOGICAL-c5145-8a0d8c9d3d79c6d9ca11bbb8b670b1473c54652ad96292d45a3d5c0ceb94022c3 |
IEDL.DBID | DR2 |
ISSN | 0954-6820 |
IngestDate | Thu Jul 10 22:20:09 EDT 2025 Wed Feb 19 02:34:49 EST 2025 Mon Jul 21 09:13:43 EDT 2025 Thu Apr 24 23:12:06 EDT 2025 Tue Jul 01 04:07:20 EDT 2025 Wed Jan 22 16:41:16 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Endocrinopathy Human Angioplasty Diabetes mellitus Lower limb Cardiovascular disease Foot Percutaneous route Arterial disease Vascular disease Treatment Ischemia Disease of the foot Occlusive arterial disease Complication Ulcer |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5145-8a0d8c9d3d79c6d9ca11bbb8b670b1473c54652ad96292d45a3d5c0ceb94022c3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2796.2002.01015.x |
PMID | 12270002 |
PQID | 72125217 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_72125217 pubmed_primary_12270002 pascalfrancis_primary_13888063 crossref_primary_10_1046_j_1365_2796_2002_01015_x crossref_citationtrail_10_1046_j_1365_2796_2002_01015_x wiley_primary_10_1046_j_1365_2796_2002_01015_x_JOIM1015 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | September 2002 |
PublicationDateYYYYMMDD | 2002-09-01 |
PublicationDate_xml | – month: 09 year: 2002 text: September 2002 |
PublicationDecade | 2000 |
PublicationPlace | Oxford UK |
PublicationPlace_xml | – name: Oxford UK – name: Oxford – name: England |
PublicationTitle | Journal of internal medicine |
PublicationTitleAlternate | J Intern Med |
PublicationYear | 2002 |
Publisher | Blackwell Science Ltd Blackwell Science |
Publisher_xml | – name: Blackwell Science Ltd – name: Blackwell Science |
References | 1995; 82 1996; 17 1993; 18 2000; 215 1999; 17 1999; 28 1999; 172 2000; 11 1992; 127 1994; 89 1994; 29 1995; 18 1999; 178 1996; 13 1998; 168 2001;; 24 1996; 200 1998; 12 2001; 358 e_1_2_5_14_2 e_1_2_5_13_2 Grollman J (e_1_2_5_9_2) 2000; 215 e_1_2_5_8_2 e_1_2_5_15_2 e_1_2_5_7_2 e_1_2_5_10_2 Melki JP (e_1_2_5_16_2) 1993; 18 e_1_2_5_22_2 e_1_2_5_6_2 e_1_2_5_5_2 e_1_2_5_12_2 e_1_2_5_20_2 e_1_2_5_4_2 e_1_2_5_11_2 e_1_2_5_21_2 e_1_2_5_3_2 e_1_2_5_2_2 e_1_2_5_18_2 e_1_2_5_17_2 e_1_2_5_19_2 |
References_xml | – volume: 82 start-page: 1232 year: 1995 end-page: 5 article-title: Percutaneous transluminal angioplasty for lower‐limb critical ischemia publication-title: Br J Surg – volume: 89 start-page: 511 year: 1994 end-page: 31 article-title: Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels. A statement for health professionals from a special writing group of the Councils on Cardiovascular Radiology, Arteriosclerosis, Cardio‐Thoracic and Vascular Surgery, Clinical Cardiology, and Epidemiology and Prevention, the American Heart Association publication-title: Circulation – volume: 24 start-page: 78 year: 2001; end-page: 83 article-title: New ulceration, new major amputation, and survival rates in diabetic subjects hospitalized for foot ulceration from 1990 to 1993: a 6.5‐year follow‐up publication-title: Diabetes Care – volume: 29 start-page: 854 year: 1994 end-page: 60 article-title: Assessment and management of foot disease in patients with diabetes publication-title: N Engl J Med – volume: 178 start-page: 151 year: 1999 end-page: 5 article-title: The benefits of secondary interventions in patients with failing or failed pedal bypass grafts publication-title: Am J Surg – volume: 172 start-page: 1335 year: 1999 end-page: 41 article-title: Diabetic versus nondiabetic limb‐threatening ischemia: outcome of percutaneous iliac intervention publication-title: Am J Roentgenol – volume: 12 start-page: 96 year: 1998 end-page: 102 article-title: Change in major amputation rate in a center dedicated to diabetic foot care during the 1980s: prognostic determinants for major amputation publication-title: J Diabetes Complications – volume: 17 start-page: 43 year: 1996 end-page: 8 article-title: Foot function in diabetic patients after partial amputation publication-title: Foot Ankle Int – volume: 17 start-page: 438 year: 1999 end-page: 41 article-title: Influence of diabetes on revascularisation procedures of the aorta and lower limb arteries: early results publication-title: Eur J Vasc Endovasc Surg – volume: 200 start-page: 33 year: 1996 end-page: 6 article-title: Percutaneous transluminal angioplasty of the infrapopliteal vessels: the evidence publication-title: Radiology – volume: 11 start-page: 1021 year: 2000 end-page: 31 article-title: Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: angiographic and clinical results publication-title: J Vasc Interv Radiol – volume: 28 start-page: 271 year: 1999 end-page: 8 article-title: Impact of different therapeutic alternatives in treatment of severe limb ischemia: experiences on 190 consecutive patients at a department of medical angiology publication-title: Vasa, – volume: 13 start-page: S6 year: 1996 end-page: S11 article-title: The epidemiology of diabetic foot problems publication-title: Diabet Med – volume: 127 start-page: 617 year: 1992 end-page: 20 article-title: Trends in the care of the diabetic foot. Expanded role of arterial reconstruction publication-title: Arch Surg – volume: 215 start-page: 95 year: 2000 end-page: 9 article-title: Recurrent symptoms following lower extremity angioplasty: claudication and threatened limb. American College of Radiology. ACR Appropriateness Criteria publication-title: Radiology – volume: 18 start-page: 37 year: 1993 end-page: 41 article-title: Treatment of diabetic arteriopathy. Importance of transluminal angioplasty publication-title: J Mal Vasc – volume: 168 start-page: 415 year: 1998 end-page: 20 article-title: Infrapopliteal angioplasty: a forgotten region? publication-title: Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr – volume: 18 start-page: 1383 year: 1995 end-page: 94 article-title: Preventing amputation in the patient with diabetes publication-title: Diabetes Care – volume: 358 start-page: 1257 year: 2001 end-page: 64 article-title: Peripheral arterial disease publication-title: Lancet – ident: e_1_2_5_7_2 doi: 10.2337/diacare.18.10.1383 – volume: 18 start-page: 37 year: 1993 ident: e_1_2_5_16_2 article-title: Treatment of diabetic arteriopathy. Importance of transluminal angioplasty publication-title: J Mal Vasc – ident: e_1_2_5_8_2 doi: 10.1161/01.CIR.89.1.511 – ident: e_1_2_5_12_2 – ident: e_1_2_5_20_2 – ident: e_1_2_5_15_2 doi: 10.1024/0301-1526.28.4.271 – ident: e_1_2_5_22_2 doi: 10.2337/diacare.24.1.78 – ident: e_1_2_5_19_2 doi: 10.1016/S1056-8727(97)98004-1 – volume: 215 start-page: 95 year: 2000 ident: e_1_2_5_9_2 article-title: Recurrent symptoms following lower extremity angioplasty: claudication and threatened limb. American College of Radiology. ACR Appropriateness Criteria publication-title: Radiology – ident: e_1_2_5_3_2 doi: 10.1148/radiology.200.1.8657939 – ident: e_1_2_5_4_2 doi: 10.1053/ejvs.1998.0806 – ident: e_1_2_5_6_2 doi: 10.1056/NEJM199409293311307 – ident: e_1_2_5_14_2 doi: 10.1016/S0002-9610(99)00149-X – ident: e_1_2_5_21_2 doi: 10.1055/s-2007-1015156 – ident: e_1_2_5_13_2 doi: 10.1002/bjs.1800820925 – ident: e_1_2_5_18_2 doi: 10.1002/dme.1996.13.s1.6 – ident: e_1_2_5_10_2 doi: 10.1177/107110079601700110 – ident: e_1_2_5_2_2 doi: 10.1001/archsurg.1992.01420050145019 – ident: e_1_2_5_17_2 doi: 10.1016/S1051-0443(07)61332-3 – ident: e_1_2_5_11_2 doi: 10.1016/S0140-6736(01)06351-6 – ident: e_1_2_5_5_2 doi: 10.2214/ajr.172.5.10227512 |
SSID | ssj0013060 |
Score | 2.1835487 |
Snippet | Faglia E, Mantero M, Caminiti M, Caravaggi C, De Giglio R, Pritelli C, Clerici G, Fratino P, De Cata P, Paola LD, Mariani G, Poli M, Settembrini PG, Sciangula... Abstract Faglia E, Mantero M, Caminiti M, Caravaggi C, De Giglio R, Pritelli C, Clerici G, Fratino P, De Cata P, Paola LD, Mariani G, Poli M, Settembrini PG,... To evaluate the feasibility, technical effectiveness and limb salvage potential of percutaneous transluminal angioplasty (PTA), particularly infrapopliteal, in... |
SourceID | proquest pubmed pascalfrancis crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 225 |
SubjectTerms | Aged Amputation Angiography Angioplasty, Balloon - adverse effects Arteries - surgery Associated diseases and complications Biological and medical sciences Diabetes. Impaired glucose tolerance Diabetic Foot - etiology Diabetic Foot - therapy diabetic foot ulcer Endocrine pancreas. Apud cells (diseases) Endocrinopathies Feasibility Studies Female Follow-Up Studies Foot - blood supply Humans infrapopliteal angioplasty Ischemia - complications Ischemia - diagnostic imaging Ischemia - therapy Leg - blood supply major amputation Male Medical sciences minor amputation peripheral arterial occlusive disease Peripheral Vascular Diseases - complications Peripheral Vascular Diseases - diagnostic imaging Peripheral Vascular Diseases - therapy Popliteal Artery - diagnostic imaging Popliteal Artery - surgery Recurrence Tibial Arteries - diagnostic imaging Tibial Arteries - surgery Treatment Outcome |
Title | Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1046%2Fj.1365-2796.2002.01015.x https://www.ncbi.nlm.nih.gov/pubmed/12270002 https://www.proquest.com/docview/72125217 |
Volume | 252 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Na9wwEBUlh1IoTdLPbdpEhx7jxZZly-qtlIQksC2UBnIzkiyXJa5t1jYk-YP9W52R7F225BBKbt6VR1jWSHrWPL0h5JPNdMQjYQMGy1vAS8UCqWQcSKkirTkrpZMvXnxLzy75xVVyNfKf8CyM14dYb7jhyHDzNQ5wpX0WktCp204MLSE902COamnJHPEkFiA--sE2AYXQHRgGQMGDFFa9kdQzBjjvrWhrpXreqg5eWumzXdwHR7fRrVueTnfJ9dQwz0q5ng-9npu7fzQfH6fle-TFiGLpF-92--SJrV-Sp4sxTv-K_Dm5GZnxdOgsbUqKgspOwaCiqv61bFpA7f3tMW2d6yIXtrql4O0r1UIZ4GBVHcNvCviUrsnwWNGyQ57_76WhftsYLsqm6elQGUCyn-l01JOubDdUfYc2ijrepCOiwv1OUhf_ZyyiBunkZsBZf1NjN2jcn-pek8vTk59fz4IxZURgAPklQabCIjOyiAshTVpIoyJwOZ3pVITglCI2mPydqUKmTLKCJyouEhMaqyV8SDMTvyE7dVPbd4SiEj6UFVwkmtswUllcotZNUloBuEnPiJjcIzejnjqm9ahyF9fneAYO-ynHfsJsnyx3_ZTfzEi0tmy9psgDbA63PHBjGGcwBafxjBxNLpnDDIFhH1XbZuhy-MZnANLEjLz1nrqxZUg7CBk0xfnbg58mv_h-vsDL9_9teUCeucQ6jq73gez0q8F-BHzX60M3cv8CRUhDgQ |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlhbZQ-n5sH4kOPcZbW5Yf6q2UhE2aTaEkkJuQZDksdW2ztiHpH-zf6ozk3WVLDqH05l17hGWNpE-aT98Q8sHmOuJRZgMG01vAS8UCoUQcCKEirTkrhZMvnp-ms3N-fJFcjOmA8CyM14dYb7hhz3DjNXZw3JD-OIYlfS_3B6qEpxpMUS4tmQKgvIsJvt366jvbhBRCd2QYIAUPUpj3RlrPGOK8saStuephqzr4bKXPd3ETIN3Gt26COnxMqlXVPC_lx3To9dT8-kv18T_V_Ql5NAJZ-tl73lNyx9bPyL35GKp_Tn4fXI3keDp0ljYlRU1lJ2JQUVVfLpoWgHt_vU9b571Ih62uKTj8UrVwD6CwqvbhNwWIStd8eCxo0SHV_-fCUL9zDBdl0_R0qAyA2U90ddqTLm03VH2HNoo66qTjosLzTlUX_2csogYZ5WbAgX9TYjdo3KLqXpDzw4OzL7NgzBoRGAB_SZCrsMiNKOIiEyYthFEReJ3OdZqF4JdZbDD_O1OFSJlgBU9UXCQmNFYLWEszE78kO3VT29eEohg-3Ct4lmhuw0jlcYlyN0lpM4BOekKylX9IM0qqY2aPSrrQPsdjcNhOEtsJE34y6dpJXk1ItLZsvazILWx2t1xwYxjnMAqn8YTsrXxSwiCBkR9V22boJCzzGeC0bEJeeVfd2DJkHoQMquIc7tZvI4-_Hc3x8s0_W-6R-7Oz-Yk8OTr9-pY8cHl2HHvvHdnpl4N9D3Cv17uuG_8BZUpHnA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1dT9swFLUmJqFJ02DfBQZ-2CPpEsf5MG_ToAK2smkaEm-R7TioIkuiJpFgf3B_a_faaatOPKBpb2nTa8X1tX3ie-65hLw3qQp4kBiPwfbm8UIyT0gRekLIQCnOCmHli6cX8eklP7-Krgb-E-bCOH2I5YEbzgy7XuMEb_LiwxCVdJPc5VMJxzQYo1paNAY8-ZjHfooefvydrSIKvs0YBkTBvRi2vYHVM0Q4721pbat62sgW_rXClbu4D4-uw1u7P022yM2iZ46WcjPuOzXWv_4Sffw_Xd8mzwYYSz86v3tOHpnqBdmcDoH6l-T3ye1Ajad9a2hdUFRUthIGJZXV9axuALZ3d4e0sb6LZNjyjoK7z2UD9wAIy_IQPlMAqHTJhseGZi0S_X_ONHXnxnBR1HVH-1IDlD2ii1xPOjdtX3Yt2khqiZOWiQq_t5q6-D1jAdXIJ9c9LvurFtte4QFV-4pcTk5-fDr1hpoRngboF3mp9PNUizzME6HjXGgZgM-pVMWJD16ZhBqrvzOZi5gJlvNIhnmkfW2UgDdppsPXZKOqK_OWUJTCh3s5TyLFjR_INCxQ7CYqTALASY1IsnCPTA-C6ljXo8xsYJ9jEhyOU4bjhOU-WWbHKbsdkWBp2ThRkQfY7K954MowTGENjsMROVi4ZAZLBMZ9ZGXqvs3gJZ8BSktG5I3z1JUtQ96Bz6Ar1t8e_DTZ-dezKV7u_LPlAdn8djzJvpxdfN4lT2yRHUvd2yMb3bw37wDrdWrfTuI_bJBGVA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Extensive+use+of+peripheral+angioplasty%2C+particularly+infrapopliteal%2C+in+the+treatment+of+ischaemic+diabetic+foot+ulcers%3A+clinical+results+of+a+multicentric+study+of+221+consecutive+diabetic+subjects&rft.jtitle=Journal+of+internal+medicine&rft.au=FAGLIA%2C+E&rft.au=MANTERO%2C+M&rft.au=MARIANI%2C+G&rft.au=POLI%2C+M&rft.date=2002-09-01&rft.pub=Blackwell+Science&rft.issn=0954-6820&rft.volume=252&rft.issue=3&rft.spage=225&rft.epage=232&rft_id=info:doi/10.1046%2Fj.1365-2796.2002.01015.x&rft.externalDBID=n%2Fa&rft.externalDocID=13888063 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0954-6820&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0954-6820&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0954-6820&client=summon |